No takes yet. Share an insight, caveat, or question.
Viability-informed mass spectrometry assesses metabolic profiles in colorectal cancer cells, suggesting significant insights into cancer therapy adaptation.
Cheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: